A nurse is preparing to administer digoxin 0.25 mg PO to a client. The amount available is digoxin 0.125 mg tablets. How many tablets should the nurse administer to the client?

(Round to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)

A. Trombin (Evithrom): Incorrect: Thrombin (also known as factor IIa) is not typically used as a hemostatic drug. It is involved in the final step of the coagulation cascade, converting fibrinogen to fibrin to form a stable clot. However, it is not administered directly as a medication.

B. Aminocaproic acid (Amicar): Aminocaproic acid is an antifibrinolytic agent commonly used to control bleeding. It works by inhibiting the breakdown of fibrin clots, thus promoting hemostasis. It is particularly useful in situations where excessive bleeding occurs due to impaired clot dissolution. However, tranexamic acid is generally considered more potent and has a longer-lasting effect, making it the preferred choice in many situations.

C. Aspirin: Incorrect: Aspirin is an antiplatelet medication that inhibits platelet aggregation. While it can reduce the risk of clot formation, it is not primarily used for controlling postoperative bleeding.

D. Tranexamic acid (Cyklokapron): Correct: Tranexamic acid is another antifibrinolytic agent that helps prevent excessive bleeding. It works by blocking the breakdown of fibrin clots. Tranexamic acid is commonly used in surgical settings to manage bleeding during and after procedures.

A. Most CAM therapies are totally ineffective: Incorrect. Dismissing all CAM therapies as ineffective without considering individual cases could lead to overlooking potentially helpful treatments for patients.

B. Additional treatment may not be needed: Incorrect. Collecting information about CAM use allows healthcare providers to assess the overall treatment regimen comprehensively.

C. Patients must be warned that most CAM therapies are dangerous: Incorrect. While some CAM therapies may carry risks, it's not accurate to generalize that most CAM therapies are dangerous.

D. CAM therapies could interact with prescription and OTC medications: Correct. Understanding potential interactions between CAM therapies and conventional medications is essential for patient safety and optimal treatment outcomes.